STAGE IIB BREAST CANCER
Clinical trials for STAGE IIB BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIB BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune booster before chemo shows promise for tough breast cancer
Disease control OngoingThis study tests whether giving two immunotherapy drugs (decitabine and pembrolizumab) before standard chemotherapy can help the immune system attack HER2-negative breast cancer more effectively. About 46 adults with locally advanced disease will receive a short course of these d…
Matched conditions: STAGE IIB BREAST CANCER
Phase: PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
New hope for tough breast cancer: which chemo works best after surgery?
Disease control OngoingThis study tests whether platinum-based chemotherapy (cisplatin or carboplatin) works better than capecitabine in people with a certain type of triple-negative breast cancer that remains after initial chemotherapy and surgery. About 415 participants with stage II-III breast cance…
Matched conditions: STAGE IIB BREAST CANCER
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Can adding a targeted drug shrink breast tumors before surgery?
Disease control OngoingThis study tests whether giving chemotherapy (paclitaxel and cyclophosphamide) with or without the targeted drug trastuzumab before surgery can shrink breast tumors and reduce the amount of tissue that needs to be removed. It includes 92 women with early-stage or locally advanced…
Matched conditions: STAGE IIB BREAST CANCER
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
Shorter radiation after mastectomy may cut side effects and prevent cancer return
Disease control OngoingThis study tests whether a shorter course of radiation (hypofractionated) after mastectomy works as well as standard radiation to keep breast cancer from coming back. About 900 people with stage II–III breast cancer who had a mastectomy and reconstruction took part. The shorter s…
Matched conditions: STAGE IIB BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
Could adding carboplatin beat triple-negative breast cancer?
Disease control OngoingThis study tested whether adding a drug called carboplatin to standard chemotherapy helps people with triple-negative breast cancer live longer without the cancer coming back. About 782 people with high-risk or node-positive breast cancer took part. The goal was to see if the str…
Matched conditions: STAGE IIB BREAST CANCER
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
One-Time radiation boost during breast surgery shows promise in Early-Stage cancer trial
Disease control OngoingThis study tests whether giving a single dose of radiation directly to the tumor site during breast-conserving surgery (lumpectomy) and before reconstruction is safe and effective for women with early-stage breast cancer. About 108 participants with stage I-II breast cancer will …
Matched conditions: STAGE IIB BREAST CANCER
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New chemo combo shows promise against tough breast cancer
Disease control OngoingThis study tested a two-drug chemotherapy combination (carboplatin and nab-paclitaxel) given before surgery to people with locally advanced or inflammatory triple negative breast cancer. The goal was to see if this approach could shrink tumors enough to improve the chances of a c…
Matched conditions: STAGE IIB BREAST CANCER
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC